Wk 7: Pharmacology of Histamines

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/22

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

23 Terms

1
New cards

what is histamine? what group is it part of?

- endogenous mediator

- autocoid group

2
New cards

what are key aspects of histamine?

1. bioactive amine synthesized from histdine

2. released to produce local effects (in the CNS and PNS)

3. role of histamine

<p>1. bioactive amine synthesized from histdine</p><p>2. released to produce local effects (in the CNS and PNS)</p><p>3. role of histamine</p>
3
New cards

what are the 3 roles of histamine

- immediate allergic response

- regulation of basal acid secretion in the stomach

- neurotransmitter and modulator of neurotransmitter release

4
New cards

Describe gell-coombs classification of hypersensitivity reactions (type I moa, clinical manifestations and timing of reaction)

MOA:

- IgE-drug complex binds mast cells with release of histamine (inflammatory mediators)

clinical manifestations

- uticaria

- angioedema

- bronchospasm

- itching

- vomiting/diarrhea, anaphylaxis

timing

- min-hours after drug exposure

<p></p><p>MOA:</p><p>- IgE-drug complex binds mast cells with release of histamine (inflammatory mediators)</p><p>clinical manifestations</p><p>- uticaria</p><p>- angioedema</p><p>- bronchospasm</p><p>- itching</p><p>- vomiting/diarrhea, anaphylaxis</p><p>timing</p><p>- min-hours after drug exposure</p>
5
New cards

Describe gell-coombs classification of hypersensitivity reactions (type II moa, clinical manifestations and timing of reaction)

MOA

- IgG or IgM antibodies directed at drug hapten coated cells

clinical manifestations

- hemolytic anemia

- neutropenia

- thrombocytopenia

timing

- variable

<p></p><p>MOA</p><p>- IgG or IgM antibodies directed at drug hapten coated cells</p><p>clinical manifestations</p><p>- hemolytic anemia</p><p>- neutropenia</p><p>- thrombocytopenia</p><p>timing</p><p>- variable</p>
6
New cards

Describe gell-coombs classification of hypersensitivity reactions (type III moa, clinical manifestations and timing of reaction)

MOA

- tissue deposition of drug antibody complex that activates complement and inflammation

clinical manifestations

- serum sickness

- fever

- rash

- vasculitis

- glomerulonephritis

timing

- 1-3 weeks after drug exposure

<p></p><p>MOA</p><p>- tissue deposition of drug antibody complex that activates complement and inflammation</p><p>clinical manifestations</p><p>- serum sickness</p><p>- fever</p><p>- rash</p><p>- vasculitis</p><p>- glomerulonephritis</p><p>timing</p><p>- 1-3 weeks after drug exposure</p>
7
New cards

Describe gell-coombs classification of hypersensitivity reactions (type IV moa, clinical manifestations and timing of reaction)

MOA

- MHC presentation of drug molecules to t cells with cytokine and inflammatory mediator release

clinical manifestations

- allergic contact dermatitis

- drug rash

timing

- 2-7 days after continuous exposure

<p></p><p>MOA</p><p>- MHC presentation of drug molecules to t cells with cytokine and inflammatory mediator release</p><p>clinical manifestations</p><p>- allergic contact dermatitis</p><p>- drug rash</p><p>timing</p><p>- 2-7 days after continuous exposure</p>
8
New cards

describe histamines triple response of lewis

A: red spot

- appears within seconds (max 1 min)

- due to direct vasodilator effect of H1

- mediated by NO production

B: Flare or red flush

- develops slowly due to induced stimulation of neuronal reflex causing vasodilation (indirect effect)

C: wheal

- swelling 1-2 min at injection site

- due to histamine effect on capillaries increasing permeability

<p>A: red spot</p><p>- appears within seconds (max 1 min)</p><p>- due to direct vasodilator effect of H1</p><p>- mediated by NO production</p><p>B: Flare or red flush</p><p>- develops slowly due to induced stimulation of neuronal reflex causing vasodilation (indirect effect)</p><p>C: wheal</p><p>- swelling 1-2 min at injection site</p><p>- due to histamine effect on capillaries increasing permeability </p>
9
New cards

what are clinical symptoms associated with histamine release (mild,mild to moderate, and severe)

mild/cutaneous

- erythema

- uricaria

- itching

mild to moderate

- skin reactions

- tachycardia

- dysrhythmias

- moderate hypotension

- mild respiratory distress

severe/anaphylactic

- severe hypotension

- V fib

- cardiac arrest

- bronchospasm

- respiratory arrest

10
New cards

what are the 4 histamine receptors? they are all ____ protein couples receptors

H1, H2, H3, H4

- G protein coupled receptors

11
New cards

what does activation of H1 receptors cause?

- itching

- stimulation of nasal mucosa secretion

- contraction of bronchial smooth muscles

-CNS: inhibits appetite and increased wakefulness

- vascular capillary dilation

- increased vascular permeability

12
New cards

what does activation of H2 receptors cause?

- induce vascular capillary dilation with H1

13
New cards

what does activation of H3 receptors cause?

-act as autoreceptors for histamainergic neurons

- promote wakefullness

14
New cards

what does activation of H4 receptors cause?

- chemotaxis of immune cells and secretion of proinflammatory cytokines

<p>- chemotaxis of immune cells and secretion of proinflammatory cytokines</p>
15
New cards

Histamine receptors

memorize

<p>memorize</p>
16
New cards

describe epinephrine as a antihistamine

MOA:

1. antagonizes H1's: reduces bronchial smooth muscle contraction

2. A1 receptor agonism: vasocontricts leading to SVR and reduced mucosal edema

3. B1 receptor agonism: incrases inotropy and HR (increasing CO)

4. B2 receptor agonism: bronchodilation and inhibition of further mediatory release from mast cells

17
New cards

describe MOA and uses for mast cell stabilizers

MOA

- prevents mast cell degranulation and release of histamine/other mediators

USES

- allergic rhinitis

- allergic eye conditions

<p>MOA</p><p>- prevents mast cell degranulation and release of histamine/other mediators</p><p>USES</p><p>- allergic rhinitis</p><p>- allergic eye conditions</p>
18
New cards

describe H1 inverse agonists

knowt flashcard image
19
New cards

1st and 2nd generation antihistamines

knowt flashcard image
20
New cards

what are pharmacological and other uses for antihistamines

pharmacological

- allergic rhinitis

- allergic conjunctivitis

- hives (urticaria)

other uses

- manage cold symptoms

- eczema

-itching from atopic dermatitis

<p>pharmacological</p><p>- allergic rhinitis</p><p>- allergic conjunctivitis</p><p>- hives (urticaria)</p><p>other uses</p><p>- manage cold symptoms</p><p>- eczema</p><p>-itching from atopic dermatitis</p>
21
New cards

describe side effects of 1st generation antihistamines

- ANTISLUD

- hypotension

- dizziness

- reflex tachycardia

- weight gain

<p>- ANTISLUD</p><p>- hypotension</p><p>- dizziness</p><p>- reflex tachycardia</p><p>- weight gain</p>
22
New cards

what are other uses for 1st gen antihistamines

- motion sickness

- acute dystonia associated with D2 receptor blockade (diphenhydramine)

<p>- motion sickness</p><p>- acute dystonia associated with D2 receptor blockade (diphenhydramine)</p>
23
New cards

describe the pathophysiology of motion sickness

-mediated by the inner ear and increased cholinergic/histaminergic neurotransmission

drugs

- scopolamine (muscarinic receptor antagonist)

- meclizine, dimenhydrinate

<p>-mediated by the inner ear and increased cholinergic/histaminergic neurotransmission</p><p>drugs</p><p>- scopolamine (muscarinic receptor antagonist)</p><p>- meclizine, dimenhydrinate</p>